Centene (CNC) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $31.31B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Healthcare Plans |
| Country | US | CEO | Sarah London |
| IPO Date | 2001-12-13 | CAGR | 30.26% |
| Employees | 61,100 | Website | www.centene.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 0.14% | Total Yield | 0.14% |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $13.32B | P/E | 25.16 | Forward P/E | 14.17 | PEG | — |
| P/S | 1.55 | P/B | 14.77 | P/CF | 44.02 | P/FCF | 50.07 |
| Sales | $198.10B | Sales 1Y | 17.02% | Sales 3Y | 35.45% | Sales 5Y | 72.15% |
| EPS | $2.52 | EPS 1Y | — | EPS 3Y | — | EPS 5Y | — |
| Sales QoQ | 0.44% | EPS QoQ | -238.84% | Sales QoQ Avg | 1.75% | EPS QoQ Avg | 526.36% |
| Gross Margin | 14.93% | Operating Margin | -3.68% | Profit Margin | -3.25% | ROCE | -17.73% |
| ROA | -8% | ROE | -29% | Altman Z Score | 2.76 | Piotroski Score | 7 |
| Current Ratio | 1.12 | Quick Ratio | 1.12 | Cash Ratio | 0.53 | Op. CF Ratio | 0.09 |
| Debt/Equity | 0.76 | Debt/Assets | 0.2 | Lt Debt/Equity | 0.76 | Lt Debt/Cap. | 0.43 |
| Intrst Cov. | -10.85 | Inventory Turnover | — | Asset Turnover | 2.44 | Receivables Turnover | 10.2 |
| Enterprise Value | $13.32B | P/E Ratio | 25.16 |
| Forward P/E | 14.17 | PEG Ratio | — |
| P/S Ratio | 1.55 | P/B Ratio | 14.77 |
| P/CF Ratio | 44.02 | P/FCF Ratio | 50.07 |
| EPS | $2.52 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | 17.02% | Gross Margin | 0.15% |
| Operating Margin | -0.04% | Profit Margin | -0.03% |
| ROE | -0.29% | ROA | -0.08% |
| ROCE | -0.18% | Current Ratio | 1.12 |
| Quick Ratio | 1.12 | Cash Ratio | 0.53 |
| Debt/Equity | 0.76 | Interest Coverage | -10.85 |
| Altman Z Score | 2.76 | Piotroski Score | 7 |
Centene (CNC) valuation & financials
Centene (CNC) has a market capitalization of $31.31B and trades at a price-to-earnings ratio of 25.2. It operates in the Healthcare sector (Medical - Healthcare Plans).
Centene's revenue grew +17.0% over the last year.
Centene's next earnings report is scheduled for July 28, 2026 before market open; analysts estimate EPS of $1.05.
Centene (CNC) — frequently asked questions
When does Centene (CNC) report earnings next?
Centene is expected to report earnings on July 28, 2026 before market open. Analysts estimate EPS of $1.05.
What is Centene's market cap?
Centene (CNC) has a market capitalization of $31.31B.
What is CNC's P/E ratio?
Centene trades at a price-to-earnings ratio of 25.2, with trailing twelve-month EPS of $2.52.
How fast is Centene growing?
Centene's revenue grew +17.0% over the last year.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)